Endometrial hyperplasia differential diagnosis: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
Line 4: | Line 4: | ||
==Overview== | ==Overview== | ||
Endometrial hyperplasia must be differentiated from | |||
==Differential Diagnosis== | ==Differential Diagnosis== | ||
Line 18: | Line 19: | ||
===Non-pregnancy related=== | ===Non-pregnancy related=== | ||
*Endometrial carcinoma (variable appearance) | *Endometrial carcinoma (variable appearance) | ||
*Polycystic | *Polycystic ovarian disease (usually uniformly hyperechoic and tends to be diffuse) | ||
*Endometrial polyp or polyps (usually hyperechoic, often focal, look for vascular stalk) | *Endometrial polyp or polyps (usually hyperechoic, often focal, look for vascular stalk) | ||
*Tamoxifen related endometrial changes (variable appearances) | *Tamoxifen related endometrial changes (variable appearances) | ||
Line 24: | Line 25: | ||
*Submucosal uterine fibroids | *Submucosal uterine fibroids | ||
*Intrauterine adhesions (irregular echogenic areas with focal thickening) | *Intrauterine adhesions (irregular echogenic areas with focal thickening) | ||
* | *Estrogen secreting ovarian tumours | ||
**Granulosa cell ovarian cancer | **Granulosa cell ovarian cancer | ||
Revision as of 16:31, 3 March 2016
Endometrial hyperplasia Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Endometrial hyperplasia differential diagnosis On the Web |
American Roentgen Ray Society Images of Endometrial hyperplasia differential diagnosis |
Risk calculators and risk factors for Endometrial hyperplasia differential diagnosis |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Soujanya Thummathati, MBBS [2]
Overview
Endometrial hyperplasia must be differentiated from
Differential Diagnosis
- Endometrial hyperplasia must be differentiated from the following:[1]
- Early pregnancy prior to sac being visualized (<5 weeks of gestation)
- Ectopic pregnancy (thickened endometrium and sometimes fluid collection or pseudogestational sac can be associated)
- Retained products of conception (heterogeneously thickened endometrium with increased vascularity)
- Adherent intra-uterine blood clot (heterogeneous endometrium with no vascularity)
- Molar pregnancy thickened with multiple small cystic spaces
- Endometritis (prominent hyperechoic endometrium with of without fluid and debris)
- Endometrial carcinoma (variable appearance)
- Polycystic ovarian disease (usually uniformly hyperechoic and tends to be diffuse)
- Endometrial polyp or polyps (usually hyperechoic, often focal, look for vascular stalk)
- Tamoxifen related endometrial changes (variable appearances)
- Hormone replacement therapy (HRT) in postmenopausal female
- Submucosal uterine fibroids
- Intrauterine adhesions (irregular echogenic areas with focal thickening)
- Estrogen secreting ovarian tumours
- Granulosa cell ovarian cancer
References
- ↑ Hulka CA, Hall DA, McCarthy K, Simeone JF (1994). "Endometrial polyps, hyperplasia, and carcinoma in postmenopausal women: differentiation with endovaginal sonography". Radiology. 191 (3): 755–8. doi:10.1148/radiology.191.3.8184058. PMID 8184058.